David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$549M |
| 2 |
CVS Health
CVS
|
+$537M |
| 3 |
Meta Platforms (Facebook)
META
|
+$515M |
| 4 |
McDonald's
MCD
|
+$386M |
| 5 |
Home Depot
HD
|
+$308M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$475M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$442M |
| 3 |
AGN
Allergan plc
AGN
|
+$435M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$369M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$330M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.73% |
| 2 | Technology | 10.93% |
| 3 | Consumer Discretionary | 10.32% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPIL
3001
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
| $292K | ﹤0.01% |
38,141
-264,297
| -87% | -$2M |
|
|
SCMP
3002
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $292K | ﹤0.01% |
26,647
-51,444
| -66% | -$576K |
|
3003
Immunic
IMUX
$225M
| $289K | ﹤0.01% |
117
+29
| +33% | +$95.3K |
|
|
SQNM
3004
DELISTED
SEQUENOM INC NEW
SQNM
| $289K | ﹤0.01% |
316,438
-204,546
| -39% | -$244K |
|
|
ADVM
3005
DELISTED
Adverum Biotechnologies
ADVM
| $288K | ﹤0.01% |
+9,121
| New | +$412K |
|
3006
LendingTree
TREE
$435M
| $288K | ﹤0.01% |
+3,265
| New | +$277K |
|
|
AGR
3007
DELISTED
Avangrid, Inc.
AGR
| $288K | ﹤0.01% |
+6,245
| New | +$257K |
|
|
ARAV
3008
DELISTED
Aravive, Inc. Common Stock
ARAV
| $288K | ﹤0.01% |
4,342
-1,694
| -28% | -$96.3K |
|
|
GBL
3009
DELISTED
GAMCO Investors, Inc.
GBL
| $288K | ﹤0.01% |
+8,778
| New | +$321K |
|
3010
Ameresco
AMRC
$1.11B
| $287K | ﹤0.01% |
65,671
+53,614
| +445% | +$244K |
|
|
HIMX
3011
Himax Technologies
HIMX
$2.34B
| $287K | ﹤0.01% |
34,781
-51,520
| -60% | -$508K |
|
|
GNBC
3012
DELISTED
Green Bancorp, Inc
GNBC
| $286K | ﹤0.01% |
32,824
-383
| -1% | -$3.1K |
|
3013
American States Water
AWR
$3.61B
| $284K | ﹤0.01% |
+6,473
| New | +$261K |
|
3014
Camden National
CAC
$961M
| $284K | ﹤0.01% |
10,157
+1,269
| +14% | +$36K |
|
3015
Tyson Foods
TSN
$20.4B
| $283K | ﹤0.01% |
4,231
-347,874
| -99% | -$22.6M |
|
3016
UBS Group
UBS
$164B
| $283K | ﹤0.01% |
21,805
+1,960
| +10% | +$29.9K |
|
3017
Ocular Therapeutix
OCUL
$2.37B
| $282K | ﹤0.01% |
56,887
-32,843
| -37% | -$325K |
|
3018
Tonix Pharmaceuticals
TNXP
$214M
| – | – |
0
| – | – |
|
|
TEN
3019
Tsakos Energy Navigation Ltd
TEN
$1.28B
| $282K | ﹤0.01% |
12,034
+10,025
| +499% | +$295K |
|
|
LTS
3020
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $282K | ﹤0.01% |
119,498
+20,685
| +21% | +$52.1K |
|
|
AMRI
3021
DELISTED
Albany Molecular Research Inc
AMRI
| $282K | ﹤0.01% |
20,959
-59,659
| -74% | -$870K |
|
|
EMKR
3022
DELISTED
Emcore Corp
EMKR
| $282K | ﹤0.01% |
4,748
-16,147
| -77% | -$910K |
|
3023
Casey's General Stores
CASY
$31.6B
| $281K | ﹤0.01% |
+2,135
| New | +$248K |
|
3024
PUT
Chord Energy
CHRD
$7.91B
| $280K | ﹤0.01% |
30,000
| – | – |
|
3025
PUT
3M
MMM
$92.3B
| $280K | ﹤0.01% |
1,914
| – | – |
|
Similar funds
David Shaw's Q2 2016 Portfolio in Review
As of Q2 2016, David Shaw held 3,766 positions worth $54.2B, down 2.7% from $55.7B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $2.46B in Q2 2016, closing 445 positions and reducing 1,324 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $369M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Liberty Media Corporation Series C Liberty SiriusXM Common Stock worth $198M.
- David Shaw's largest Q2 2016 buy was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 8,430,023 shares worth $198M.
- David Shaw added most to Amazon in Q2 2016, an estimated $549M increase.
- David Shaw's biggest Q2 2016 reduction was Booking.com, cutting an estimated $475M.
- David Shaw fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $369M.
- David Shaw's ten largest holdings make up 9.2% of its $54.2B portfolio in Q2 2016.
- David Shaw opened 402 new positions and closed 445 in Q2 2016.
- David Shaw's portfolio value fell 2.7% quarter-over-quarter to $54.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.